With FDA's blessing, PhysioSonics looks to market brain monitor

PhysioSonics, a University of Washington spinout, snagged FDA clearance for its Presto 1000 Flow Monitor, and now the company is on the hunt for a commercial partner, Xconomy reports. The device allows physicians to automate brain blood flow monitoring of stroke patients, providing a continuous readout instead of the period snapshots generated by ultrasound transducers. PhysioSonics has raised a total of $22 million from investors and government sources, according to Xconomy, and it aims to get the device on the market next year. Report

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.